Delivery Order SPE2DB24D1205-SPE2DB25FCSVQ
Award Date
1/7/25
Potential Completion Date
1/29/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $5,785.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYEPTI 100 MG/ML vials, a prescription medication, with a completion date of January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,270.04, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $6,405.06 firm fixed price delivery order is for VYEPTI 100 MG/ML VIALML, a specialty pharmaceutical product. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of VYEPTI 100 MG/ML vials. The $21,350.20 contract has a completion date of February 15, 2024 and does not include a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products, including VYEPTI 100 MG/ML vials. The $4,270.04 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYEPTI 100 MG/ML VIALML. The $9,607.59 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of October 9, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract as well as several Indefinite Delivery Contracts (IDCs) by the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,357.70, is for the delivery of VYEPTI 100 MG/ML VIALML, a medical product. This is a firm fixed-price delivery order contract with a completion date of March 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,202.53, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of June 13, 2024. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,337.55 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIAL, a specialty pharmaceutical product. The order has an ultimate completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...